• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2026, Vol. 28 ›› Issue (5): 690-696.DOI: 10.3969/j.issn.1671-2587.2026.05.004

Previous Articles     Next Articles

Inhibition of ADP- and Thrombin-Induced Human Platelet Activation by Quercetin in Vitro

GE Haoran, CHEN Xin, YAN Meiling, YANG Jie, SHAO Xiaobao, ZHOU Lin, ZHU Peiyuan   

  1. Department of Transfusion Medicine, Nanjing Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing 210022
  • Received:2026-09-02 Revised:2026-09-21 Online:2026-10-20 Published:2026-11-11

Abstract: Objective To verify the antiplatelet effects of quercetin (Qu), the main component of Guizhi Fuling Pill, using blood samples from healthy individuals. Methods Thromboelastography was used to measure the inhibition rates of platelets in response to arachidonic acid (AA) and adenosine diphosphate (ADP) after treatment with different concentrations of Qu. Using flow cytometry, we quantified the CD62P and PAC-1 expression levels in platelets exposed to varying concentrations of Qu. Platelet thromboxane B2 (TXB2 ) levels were also assessed by ELISA after incubation with different concentrations of Qu. Results Thromboelastography showed ADP and AA inhibition rates of the control group matched those in normal unactivated samples. Low-, medium-, and high-concentration quercetin (Qu, 10, 20, 40 μmol/L) groups exhibited significant differences in ADP and AA inhibition rates compared with blank controls (all P<0.01). Pairwise comparisons among the Qu groups showed a significant difference in the AA inhibition rate between Qu 10 μmol/L and Qu 40 μmol/L (P<0.05). Flow cytometry revealed CD62P and PAC-1 expression rates were markedly higher in positive controls than in blank controls (all P<0.01). Under thrombin stimulation, CD62P and PAC-1 expression levels at all three Qu concentrations differed significantly from those in positive controls (all P<0.01). Under ADP stimulation, only PAC-1 expression in the Qu 10 μmol/L group showed a statistically significant difference versus that in positive controls (P<0.05), whereas other Qu groups had significant differences (all P<0.01); no intergroup differences were detected among the three Qu concentrations (all P>0.05). ELISA showed TXB2 levels in agonist-activated positive controls were significantly different from those of blank controls (P<0.01). In the thrombin-activated system, TXB2 levels differed significantly in the Qu 10 μmol/L group (P<0.05) and showed a highly significant difference in the Qu 40 μmol/L group (P<0.01). In the ADP-activated system, Qu 10 μmol/L showed no significant change in TXB2 levels; Qu 20 μmol/L had a statistically significant difference (P<0.05), and Qu 40 μmol/L displayed a highly significant difference (P<0.01). No significant differences were observed among the Qu treatment groups (all P>0.05). Conclusion Qu exerts an inhibitory effect on platelet activation, specifically suppressing the activation triggered by ADP and thrombin.

Key words: Quercetin, Platelet activation, Mechanism of action

CLC Number: